Biomarker for Farber Disease (BioFarber)
NCT02298634 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Farber disease from the blood
Conditions
- Farber's Lipogranulomatosis
- Ceramidase Deficiency
- Hepatomegaly
- Splenomegaly
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Egypt
- Germany
- India
Study Locations
More Related Trials
-
Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis
NCT01293318 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease
NCT05095623 ·Status: TERMINATED
-
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
NCT07062523 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency
NCT01568736 ·Status: WITHDRAWN
-
Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease
NCT05868538 ·Status: COMPLETED
-
MicroRNAs as Biomarkers in Patients With Chagas Disease
NCT01842880 ·Status: COMPLETED
-
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
NCT05915897 ·Status: TERMINATED
-
ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B
NCT01633554 ·Status: UNKNOWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
NCT07003451 ·Status: NOT_YET_RECRUITING
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
NCT02899039 ·Status: COMPLETED ·Phase: NA
-
Study of New Biological Markers for Prediction of Severe Acute Pancreatitis
NCT00786591 ·Status: COMPLETED
-
Glycosylated Ferritin in Macrophagic Activation Syndromes
NCT02143986 ·Status: RECRUITING
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Assessment of Endocan Serum Levels in Patients With Behcet Disease
NCT03853135 ·Status: COMPLETED
-
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906 ·Status: RECRUITING ·Phase: PHASE2
-
Giant Cell Arteritis - Optimization of Diagnostics
NCT05248906 ·Status: COMPLETED
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
Discrimination of DILI and AIH by Artificial Intelligence
NCT05532345 ·Status: COMPLETED
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED